English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy Journal article
Wang, Rui, Song, Wenqin, Zhu, Jie, Shao, Xinyue, Yang, Chenxiao, Xiong, Wei, Wang, Bing, Zhao, Pengfei, Chen, Meiwan, Huang, Yongzhuo. Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy[J]. Journal of Controlled Release, 2024, 368, 84-96.
Authors:  Wang, Rui;  Song, Wenqin;  Zhu, Jie;  Shao, Xinyue;  Yang, Chenxiao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:10.5/10.6 | Submit date：2024/05/02
Albumin  Anti-glioma  Brain-targeted Delivery  Diethyldithiocarbamate Cu/fe  Ferroptosis  Immunogenic Cell Death  Lactoferrin  Metalloimmunology  
Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes Journal article
Zhu, Jie, Wang, Rui, Yang, Chenxiao, Shao, Xinyue, Zhang, Yi, Hou, Jiazhen, Gao, Yanrong, Ou, Ante, Chen, Meiwan, Huang, Yongzhuo. Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes[J]. Journal of Controlled Release, 2024, 366, 328-341.
Authors:  Zhu, Jie;  Wang, Rui;  Yang, Chenxiao;  Shao, Xinyue;  Zhang, Yi; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:10.5/10.6 | Submit date：2024/02/22
Circulating Tumor Cells (Ctcs)  Glycolysis  Hybrid-membrane Liposome  Metastasis  Platelet  Quercetin  Shikonin  
Research and development of mAb drugs in China: a look from policy perspectives Journal article
Rong Jiang, Yuanyuan Sun, Carolina Ung, Xinyue Dong, Xiangjun Kong, Yuanjia Hu, Rong Shao. Research and development of mAb drugs in China: a look from policy perspectives[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15(11), 2695-2705.
Authors:  Rong Jiang;  Yuanyuan Sun;  Carolina Ung;  Xinyue Dong;  Xiangjun Kong; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:4.1/4.2 | Submit date：2020/03/12
r&d Support And Guidance Policy  Clinical Trial Policy  Drug Lag  Innovation Support System  Mab Drugs  Marketing Approval Policy